<<What could they possibly take 6-9 months to determine this modality, and why can't they do selective programmed release with warnings while they move into more testing?
It makes zero sense and people are suffering, to include the shareholders.>>
I have no idea where you got the 6-9 months from. It is contrary to what KM suggested at the SGCowen conf.
As for the writhing agony endured by the Eln shareholders (including me) by such a lengthy, hypothesized delay, that holds no measure against those with MS whose TY treatment was halted by the suspension. Holds nothing absolutely at all.